Latest Commercial Operations News

EBR Systems’ new Santa Clara manufacturing facility has entered the FDA’s pre-approval inspection process, marking a key regulatory step for its wireless cardiac pacing business. The company continues to expect approval by the end of 2026, but the inspection does not yet amount to clearance.

Forrestania Resources has signed agreements giving it access to up to 2 million tonnes of third-party ore and a five-year framework for future mining services. Initial supply is expected from stockpiles at MEGA Resources’ Taipan open pit, although volumes, timing and financial returns remain uncommitted.

FBR Limited secures A$4 million through a discounted placement and share purchase plan to fund development and deployment of its DST-enabled robotics products, including Mantis welding and Hadrian bricklaying robots.

WasteCo Group is raising $2 million through a share placement at $0.007 per share to finance a comprehensive turnaround and expansion plan amid ongoing financial challenges and a leadership overhaul.

Vitrafy Life Sciences has secured its first US cell and gene therapy foothold by deploying its cryopreservation technology at Charter Medical's Innovation Hub, signalling a strategic expansion into a high-value biopharma segment.

Peppermint Innovation Limited posted a $2.4 million net loss for FY26 as it shifted from platform development to commercial execution in the Philippines, achieving key regulatory milestones and securing strategic investment.

Embelton Limited has reported a solid 20.4% increase in revenue and a 34.7% jump in profit after tax for FY2026, underpinned by a strategic pivot away from residential construction towards infrastructure and social sectors. The company held its dividend steady amid improving cash flow and reduced borrowings.

Palisade Metals has boosted its Finley Basin Tungsten Project landholding by 87% to over 696 hectares, setting the stage for maiden drilling in Q3 2026 aimed at validating historical tungsten mineralisation in Montana.

Resouro Strategic Metals reported a $1.01 million loss for Q1 2026 while advancing its Tiros Rare Earths and Titanium Project with a robust Preliminary Economic Assessment and closed a $2.5 million private placement.

Cyclopharm Limited posted a fifth consecutive record half-year revenue of $17.5 million, propelled by a 74% jump in US Technegas® sales and a doubling of revenue-generating US sites. New US clinical guidelines naming Technegas® as the preferred ventilation imaging agent underpin a robust growth outlook despite a wider net loss.

Elevra Lithium has secured a binding seven-year supply agreement with Mangrove Lithium for spodumene concentrate from its North American Lithium site, anchoring a key feedstock for Mangrove’s planned Canadian lithium conversion facility.

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.